OutcomesOutcome
Late- onset sepsis incidence (neonatal)
1 finding from 1 compound ↓reported in risk ratio
What moved it
How to read these marks1 finding · 1 compound · by evidence strength. No dose is advised.
Late-onset sepsis incidence (neonatal)
Findings drawn, by strength
1finding · 1 compound
- Very limited1
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
Not pooled · no summary effect · point at a mark · Tab, then the arrow keys
Reported to move it1 finding
- lactoferrinMoved: lowersEffect, as reportedRR0.34[0.17 to 0.7]Evidence: Very limitedPaper: PMID 198090232009
- Who
- Very low birth weight (<1500 g) neonates in 11 Italian tertiary neonatal intensive care units
- Dose studied
- 100 mg/day orally from birth until day 30 of life (day 45 for neonates <1000 g at birth)
Incidence of late-onset sepsis was significantly lower in the BLF and BLF plus LGG groups (9/153 [5.9%] and 7/151 [4.6%], respectively) than in the control group receiving placebo (29/168 [17.3%]) (risk ratio, 0.34; 95% confidence interval, 0.17-0.70; P = .002 for BLF vs control and risk ratio, 0.27; 95% confidence interval, 0.12-0.60; P < .001 for BLF plus LGG vs control).”
Quoted verbatim from Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.RCTPermalink
No row matches these filters.
How it is measured
Proportion of neonates who develop late-onset sepsis, sepsis arising after the first 72 hours of life (48 hours where the source draws the line there), over a stated period. The case definition is recorded with each finding: culture-proven sepsis, clinical sepsis, or the two together as confirmed or suspected sepsis; a culture-proven count is compared only with a culture-proven count.
Partial overlaps, not equivalences
- HP:0040187
Papers about it
As an endpoint3
Show the papersHide the papers
Effect of bovine lactoferrin on prevention of late-onset sepsis in infants <1500 g: a pooled analysis of individual patient data from two randomized controlled trials.
Biochemistry and cell biology2021PMID 32931708Via: named in the paper, as read
Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g.
The Pediatric infectious disease journal2015PMID 25973934Via: named in the paper, as read
Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.
JAMA2009PMID 19809023Via: named in the paper, as read
Newest
Effect of bovine lactoferrin on prevention of late-onset sepsis in infants <1500 g: a pooled analysis of individual patient data from two randomized controlled trials.
Biochemistry and cell biology2021PMID 32931708As an endpoint
Randomized controlled trial of lactoferrin for prevention of sepsis in peruvian neonates less than 2500 g.
The Pediatric infectious disease journal2015PMID 25973934As an endpoint
Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial.
JAMA2009PMID 19809023As an endpoint
Sources cited
1 paper